Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Receivables (2021 - 2024)

Historic Receivables for Roivant Sciences (ROIV) over the last 4 years, with Q4 2024 value amounting to $678000.0.

  • Roivant Sciences' Receivables fell 9834.95% to $678000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $678000.0, marking a year-over-year decrease of 9834.95%. This contributed to the annual value of $678000.0 for FY2024, which is 9834.95% down from last year.
  • Latest data reveals that Roivant Sciences reported Receivables of $678000.0 as of Q4 2024, which was down 9834.95% from $1.9 million recorded in Q3 2024.
  • In the past 5 years, Roivant Sciences' Receivables registered a high of $79.8 million during Q2 2024, and its lowest value of -$96.6 million during Q2 2021.
  • Moreover, its 4-year median value for Receivables was $9.8 million (2021), whereas its average is $9.2 million.
  • In the last 5 years, Roivant Sciences' Receivables skyrocketed by 68336.77% in 2023 and then tumbled by 9834.95% in 2024.
  • Over the past 4 years, Roivant Sciences' Receivables (Quarter) stood at $8.9 million in 2021, then surged by 213.5% to $28.0 million in 2022, then surged by 46.88% to $41.1 million in 2023, then crashed by 98.35% to $678000.0 in 2024.
  • Its Receivables was $678000.0 in Q4 2024, compared to $1.9 million in Q3 2024 and $79.8 million in Q2 2024.